文献速递急性肾损伤血液净化与透析

急性肾损伤肾脏替代治疗强度与透析独立恢复:系统综述与个体患者数据meta分析

Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该个体患者数据meta分析纳入7项随机对照试验共3682例重症急性肾损伤患者,比较高强度与标准强度肾脏替代治疗。结果显示两组28天死亡率相似,但高强度组28天时透析依赖比例更高、停止透析时间更长,提示高强度治疗可能延迟肾脏恢复。

要点

  • 高强度肾脏替代治疗不改善重症急性肾损伤患者28天死亡率。
  • 高强度组28天透析依赖比例更高,停止透析时间更长。
  • 以连续性肾脏替代治疗起始时,高强度组停止治疗时间亦更长。

核心结论

  • 重症急性肾损伤患者中,高强度肾脏替代治疗不影响死亡率,但似乎延迟肾脏恢复。

研究设计与样本

  • 个体患者数据meta分析,合并比较高强度与标准强度肾脏替代治疗的随机对照试验,共7项试验纳入分析(n=3682)。

主要发现

  • 28天死亡率两组相似:高强度组769/1884(40.8%)vs 标准强度组744/1798(41.4%),P=0.40。
  • 28天时高强度组透析依赖比例更高:292/983(29.7%)vs 235/943(24.9%),相对风险1.15(95%CI 1.00-1.33),P=0.05。
  • 至28天停止肾脏替代治疗的时间在高强度组更长(log-rank检验P=0.02),以连续性肾脏替代治疗为初始模式时亦更长(log-rank检验P=0.03)。

临床怎么用

  • 重症急性肾损伤行肾脏替代治疗时,不宜仅以提高强度来追求改善生存或加速透析脱离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no consensus whether higher intensity dose renal replacement therapy (RRT) compared with standard intensity RRT has survival benefit and achieves better renal recovery in acute kidney injury (AKI). METHODS: In an individual patient data meta-analysis, we merged individual patient data from randomized controlled trials (RCTs) comparing high with standard intensity RRT in intensive care unit patients with severe AKI. The primary outcome was all-cause mortality. The secondary outcome was renal recovery assessed as the proportion of patients who were RRT dependent at key trial endpoints and by time to the end of RRT dependence. RESULTS: Of the eight prospective RCTs assessing different RRT intensities, seven contributed individual patient data (n = 3682) to the analysis. Mortality was similar between the two groups at 28 days [769/1884 (40.8%) and 744/1798 (41.4%), respectively; P = 0.40] after randomization. However, more participants assigned to higher intensity therapy remained RRT dependent at the most common key study point of 28 days [e.g. 292/983 (29.7%) versus 235/943 (24.9%); relative risk 1.15 (95% confidence interval 1.00-1.33); P = 0.05]. Time to cessation of RRT through 28 days was longer in patients receiving higher intensity RRT (log-rank test P = 0.02) and when continuous renal replacement therapy was used as the initial modality of RRT (log-rank test P = 0.03). CONCLUSIONS: In severe AKI patients, higher intensity RRT does not affect mortality but appears to delay renal recovery. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR) identifier ACTRN12615000394549 (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12615000394549).

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wang Y, Gallagher M, Li Q, et al. Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis. Nephrol Dial Transplant. 2018. PMID: 29186517. doi:10.1093/ndt/gfx308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。